Thought Leadership: The Toxic Substances Control Act and the Bioeconomy: Part 1, The Impact of Nomenclature on the Commercialization of Biobased Chemicals; Part 2, Reportable Substances across the Manufacturing Process; Part 3, Call to Action
by Richard E. Engler, Ph.D. (Bergeson & Campbell, P.C. and The Acta Group) When I meet people from bioeconomy companies, I ask them about their products’ status under the Toxic Substances Control Act (TSCA). The most common answers I receive are: